EXOZ - Prakiraan gabungan firma investasi Invizyne Technologies, Inc.

Logo korporat perusahaan Invizyne Technologies (EXOZ)

eXoZymes Inc (EXOZ) is an innovative startup developing cell-free enzymes through R&D partnerships with major corporations. This chart reflects the current market value on the GURU.Markets platform at 0.00. The company generates revenue by implementing eco-friendly biomanufacturing systems for fuels and pharmaceuticals. Furthermore, the development of biocatalysts for various industries allows the business to effectively mitigate potential regulatory threats.

EXOZ Target konsensus Invizyne (13.02.2025 - 22.10.2026)

Rincian analitis perusahaan Invizyne Technologies, Inc. (EXOZ)

Analisis umum perusahaan:EXOZ invizyne.com
Barang unggulan Invizyne

The market consensus target for eXoZymes Inc (EXOZ) reflects the capitalization potential of a biotechnology business whose innovations in cell-free fermentation promise high margins and stable free cash flow. This indicator represents a weighted average of target prices from leading analysts, aggregating market expectations into a single trajectory to objectively assess the company's fundamental value and minimize the impact of short-term volatility.

Pesaing eXoZymes Inc

HLN - Rata-rata rega prakiraan|Kenvue - Target konsensus|VRNA: Prakiraan gabungan firma investasi|MENS - Bagan rega target|Rata-rata rega prakiraan Ligand Corp|AMRX (Amneal Pharmaceuticals) - Target konsensus|Bagan tingkat prakiraan PRGO (perrigo.com)|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Bagan rega target|Target konsensus Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis Tectonic|Target konsensus TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Konsensus nilai wajar|Bagan rega target Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Rata-rata rega prakiraan|ORMP: Target konsensus|Entera Bio Ltd. - Rega prakiraan analis|HYFT: Prakiraan konsensus analis|ABVC BioPharma Inc. - Konsensus nilai wajar|CPIX (Cumberland Pharma) - Prakiraan konsensus analis|Rata-rata rega prakiraan Quantum BioPharma Corp QNTM|Bagan rega target FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Konsensus nilai wajar|Prakiraan konsensus analis RANI (Rani Therapeutics Holdings, Inc.)|Synergy CHC Corp. (SNYR) - Rata-rata rega prakiraan|RLYB: Target konsensus|LEXX (Lexaria Bioscience) - Prakiraan gabungan firma investasi|Pulmatrix, Inc. (PULM) - Bagan rega target|Rata-rata rega prakiraan Pheton Holdings (PTHL)|Target konsensus APM|Lyra Therapeutics Inc. - Bagan tingkat prakiraan|Target konsensus IBO (Impact BioMedical Inc)|TNFA - Rata-rata rega prakiraan|Bagan rega target cbdMD YCBD|PRFX - Target konsensus|Auris Medical - Prakiraan konsensus analis|Rata-rata rega prakiraan Lipella Pharmaceuticals Inc|Optinose (OPTN) - Bagan rega target|PIRS - Target median analis|Target konsensus PROC|PTPI: Konsensus nilai wajar|Prakiraan konsensus analis QLI|Target median analis Acelyrin Inc.|Bagan rega target TFF Pharma TFFP